In vitro evaluation of calphostin c as a novel agent for photodynamic therapy of bladder cancer

Urology

Volumn 54, Issue 3, 1999, Pages 573-577

  Beck, Traci P ^b   Kirsh, Edward J ^b   Chmura, Steven J ^b   Kovar, David A ^b   Chung, Theodore ^b   Rinker Schaeffer, Carrie W ^b   Stadler, Walter M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CALPHOSTIN C; PHOTOSENSITIZING AGENT; PROTEIN KINASE C INHIBITOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CELL VIABILITY; CHROMOSOME 9P; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; GENE DELETION; HUMAN; HUMAN CELL; LIGHT EXPOSURE; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NAPHTHALENES; PHOTOCHEMOTHERAPY; PROTEIN KINASE C; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032856040     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00210-1     Document Type: Article

References (25)

1. Landis SH, Murray T, Bolden S, et al: Cancer statistics, 1998. CA Cancer J Clin 49: 8-31, 1999.
2. Soloway MS: Intravesical therapy for bladder cancer. Urol Clin North Am 15: 661-669, 1988.
3. Heney NM, Ahmed S, Flanagan MJ, et al: Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086, 1983.
4. Nseyo UO, Doughterty TJ, Boyle DG, et al: Whole bladder photodynamic therapy for transitional cell carcinoma of the bladder. Urology 26: 274-280, 1985.
5. Nseyo UO, and Lamm DL: Therapy of superficial bladder cancer. Semin Oncol 23: 598-604, 1996.
6. Dubauskas Z, Beck TP, Chmura SJ, et al: Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential. Clin Cancer Res (in press).
7. Diwu Z, Lown JW: Phototherapeutic potential of alternative photosensitizers to porphoryins. Pharmacol Ther 63: 1-35, 1994.
8. Grossman HB, Wedemeyer G, Ren L, et al: Improved growth of human urothelial carcinoma cell cultures. J Urol 136: 953-959, 1986.
9. Rigby CC, and Franks LN: Human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosome pattern and ultrastructure. Br J Cancer 24: 746-754, 1970.
10. Williams RD: Human urologic cancer cell lines. Invest Urol 17: 359-363, 1980.
11. Mossman T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
12. Raab O: Uber die wirkung fluoreszierender stoffe auf infuroriea. Z Biol 19: 524-546, 1900.
13. Benson RC: Laser photodynamic therapy for bladder cancer. Mayo Clin Proc 61: 859-864, 1986.
14. Nseyo UO, Dougherty TJ, Sullivan L, et al: Photodynamic therapy in the management of resistant lower tract urinary cancer. Cancer 60: 3113, 1987.
15. Prout GR, Lin CW, Benson R, et al: Photodynamic therapy with hematoporphorin derivative in the treatment of superficial transitional cell carcinoma of the bladder. N Engl J Med 317: 1251-1255, 1987.
16. Jocham D, Beer M, Baumgartner R, et al: Long-term experience with the integral photodynamic therapy of Tis bladder carcinoma. Ciba Found Symp 146: 198-215, 1989.
17. Nseyo UO: Photodynamic therapy. Urol Clin North Am 19: 591-599, 1992.
18. Harty JI, Amin M, Weiman TJ, et al: Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol 141: 1341, 1989.
19. Rieger KM, Little AF, Swart JM, et al: Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer 72: 683-690, 1995.
20. Stadler WM, Sherman J, Bohlander SK, et al: Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res 54: 2060-2063, 1994.
21. Diwu Z, and Lown JW: Photosensitization with anticancer agents 19. EPR studies of photodynamic action of calphostin C: formation of semiquinone radical and activated oxygen on illumination with visible light. Free Radic Biol Med 16: 645-652, 1992.
22. Diwu Z, and Lown JW: Photosensitization with anticancer agents 15. Perlenequinoid pigments as potential photodynamic therapeutic agents: formation of semiquinone radicals and reactive oxygen species on illumination. J Photochem Photobiol B Biol 18: 131-143, 1993.
23. Bruns RF, Dean M, Merriman RL, et al: Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Commun 176: 288-293, 1991.
24. Weller M, Trepel M, Grimmel C, et al: Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurol Res 19: 459-470, 1997.
25. Jarvis WD, Turner AJ, Povirk LF, et al: Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocy tic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res 54: 1707-1714, 1994.